TGA Approval

IMFINZI durvalumab (rch) 120 mg concentrated injection vial (283215)

ARTG ID

283215

ARTG Name

IMFINZI durvalumab (rch) 120 mg concentrated injection vial

Sponsor

AstraZeneca Pty Ltd

ARTG Date

October 1, 2018

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

ASTRAZENECA PTY LTD

https://medical-cdn.nocode.com/drug_tga/607018c2ce26a318cc9bc8b1870f3154.pdf

https://medical-cdn.nocode.com/drug_tga/c66c7847365c5cd6a81fe8dd142963b8.pdf

Ingredient Name

durvalumab

Empowering clinical research with data-driven insights and AI-powered tools.

IMFINZI durvalumab (rch) 120 mg concentrated injection vial (283215) - TGA 批准文号 | MedPath